An interventional study of Video-Assisted Fun-Core Exercise Program and Home-Based Core Stabilization Exercise Program in Developmental Coordination Disorder (DCD), sponsored by Istanbul University. Not yet recruiting. Open to participants aged 5 Years to 14 Years. Per ClinicalTrials.gov, last updated 2026-10-09.
Sponsored by Istanbul University · Not applicable, Interventional, and Treatment
This single-center, single-blind, prospective randomized controlled trial aims to investigate the effects of a video-assisted core stabilization exercise program (Fun-Core) on motor competence, balance, and gait in children with DCD. Children who meet the eligibility criteria will be randomly assigned to either the intervention group or the control group. The intervention group will participate in a video-assisted, story-based, child-friendly Fun-Core exercise program delivered through a web-based platform, whereas the control group will receive the same core stabilization exercises as a home-based program provided in an illustrated brochure format. In both groups, the intervention will last 8 weeks, with exercises performed 3 days per week for approximately 30 minutes per session. The exercise program will consist of two progressive levels, with Level 1 performed during weeks 1-4 and Level 2 during weeks 5-8. Progression to Level 2 will depend on correct and pain-free performance of the exercises, completion of at least 75% of the planned sessions, and absence of exercise-related adverse events.
The primary outcome will be motor competence, assessed using the Movement Assessment Battery for Children-Third Edition (MABC-3). The MABC-3 evaluates motor performance across three domains: Manual Dexterity, Aiming and Catching, and Balance. Raw performance scores are converted into age-adjusted standard scores and percentile ranks, with higher scores indicating better motor performance.
Secondary outcomes will include balance, functional mobility, participation, health-related quality of life, and static and dynamic pedobarographic parameters. Balance will be evaluated using the Pediatric Balance Scale (PBS), a 14-item scale scored from 0 to 56, with higher scores representing better balance performance. Functional mobility will be evaluated using the Modified Timed Up and Go Test (M-TUG) by recording the time required to stand from a chair, complete the specified mobility task, return, and sit down; shorter completion times indicate better functional mobility. Participation and environmental factors will be evaluated using the Participation and Environment Measure for Children and Youth (PEM-CY), a parent-reported measure assessing participation across home, school, and community settings. Health-related quality of life will be assessed using the Pediatric Quality of Life Inventory 4.0 (PedsQL 4.0), including physical, emotional, social, and school functioning domains, using child self-report and parent proxy-report forms. Scores are transformed to a 0-100 scale, with higher scores indicating better health-related quality of life.
Gait and plantar loading characteristics will additionally be evaluated using static and dynamic pedobarographic assessment with a pressure platform integrated with FreeStep 2.0 software. Static assessment will include plantar pressure distribution, right-to-left load distribution, forefoot-to-rearfoot load distribution, and center of pressure (CoP) parameters. Dynamic assessment during walking at a self-selected natural speed will include plantar pressure distribution, maximum plantar pressure, load transfer patterns, and gait-line parameters.
All outcome assessments will be performed by an investigator blinded to group allocation at baseline (Week 0), immediately after the 8-week intervention (Week 8). During the intervention period, participants will be contacted weekly to monitor exercise adherence, general health status, and possible adverse events.
Eligible participants will be children aged 5-14 years who meet the DSM-5 diagnostic criteria for DCD and have an MABC-3 Total Standard Score corresponding to the 16th percentile or below. Exclusion criteria will include treatment for motor problems within the previous 6 months; a neurological disorder that primarily explains the motor difficulties; intellectual disability that substantially interferes with participation in assessments or exercises; moderate-to-severe autism spectrum disorder or attention-deficit/hyperactivity disorder, or behavioral problems that interfere with participation; orthopedic deformities preventing exercise; previous lumbar or lower-extremity surgery; moderate-to-severe visual or hearing impairment; and epilepsy or another uncontrolled neurological condition.
98 studies on the registry are indexed under Motor Skills Disorders; 26 are open to participants now.
This study's planned enrollment of 22 is below the median of 40 across 71 interventional studies indexed under Motor Skills Disorders.
Browse Motor Skills Disorders studies →Istanbul University is the lead sponsor of 507 studies on the registry; 80 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 1 (20%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Movement Assessment Battery for Children-Third Edition (MABC-3) Total Standard Score at or below the 16th percentile.
Exclusion Criteria:
Presence of intellectual disability at a level that would significantly interfere with the ability to participate in the assessments or exercise program.
Presence of moderate-to-severe Autism Spectrum Disorder (ASD) or Attention-Deficit/Hyperactivity Disorder (ADHD), or behavioral problems severe enough to interfere with participation in the assessments or exercise program.
Presence of an orthopedic deformity that may prevent participation in the exercise program.
History of lumbar spine or lower-extremity surgery. Moderate-to-severe visual or hearing impairment. Epilepsy or any uncontrolled neurological condition.
Behavioral: Video-Assisted Fun-Core Exercise Program
Behavioral: Home-Based Core Stabilization Exercise Program
An 8-week progressive core stabilization exercise program delivered through a web-based platform using video-assisted, story-based exercise content. Exercises will be performed three times per week for approximately 30 minutes per session.
An 8-week progressive home-based core stabilization exercise program provided in an illustrated brochure format. Exercises will be performed three times per week for approximately 30 minutes per session.
Movement Assessment Battery for Children-Third Edition (MABC-3)
The Movement Assessment Battery for Children-Third Edition (MABC-3) will be used to assess overall motor competence. The MABC-3 consists of eight motor tasks across three domains: Manual Dexterity, Aiming and Catching, and Balance. Raw scores are converted into age-adjusted standard scores using normative data. The MABC-3 Total Motor Score will be used as the primary outcome measure, with higher scores indicating better overall motor performance.
Time frame: From baseline to 8 weeks (end of intervention)
No study locations are listed for this record.
Plan to share: Undecided
No publications or documents are linked to this record.
Start is estimated for Oct 2026; primary completion for Dec 2026, 2 months later.
Of 44 non-industry interventional studies with no phase under Motor Skills Disorders, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 39. This study's planned 2 months is below that.
Counting every sponsor, half of 44 studies reached it within 17 months; a quarter within 6 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.